Effectiveness of Psychobiotic Bifidobacterium breve BB05 in Managing Psychosomatic Diarrhea in College Students by Regulating Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled Trial

Author:

Wang Yufan12,Wang Yufei2,Ding Kunpeng3,Liu Yuhan2,Liu Dingming2ORCID,Chen Weijun4,Zhang Xinyi2,Luo Chuanlin2,Zhang Hongyan1,Xu Tangchang5,Chen Tingtao167ORCID

Affiliation:

1. Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China

2. Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330031, China

3. Second College of Clinical Medicine, Nanchang University, Nanchang 330031, China

4. The Reproductive Hospital, Jiangxi University of Traditional Chinese Medicine, Nanchang 330031, China

5. School of Life Sciences, Nanchang University, Nanchang 330031, China

6. National Engineering Research Centre for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China

7. School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, China

Abstract

Diarrhea of college students (DCS) is a prevalent issue among college students, affecting their daily lives and academic performance. This study aims to explore the potential effect of Bifidobacterium breve BB05 supplements on the DCS. Initially, fifty healthy and fifty diarrheal students were recruited in the observational experiment and allocated into control and diarrhea groups, respectively. Subsequently, one hundred diarrheal students were newly recruited in the intervention experiment and randomly allocated into placebo and probiotic groups, both treated for 2 weeks. Questionnaires (BSS, HAMA-14, and HDRS-17) were performed to assess the students’ diarrheal states and mental health at baseline and post-treatment. Fecal samples underwent 16S rRNA sequencing and Enzyme-Linked Immunosorbent Assay to evaluate gut microbiota and fecal metabolite alternations. Results indicated that B. breve BB05 supplementation significantly enriched (p < 0.05) the reduced gut microbial diversity caused by diarrhea. Diarrhea resulted in notable alterations in gut microbiota composition, as exhibited by elevated Collinsella and Streptococcus, alongside substantially decreased Bifidobacterium, Bacteroides, and Prevotella, while B. breve BB05 supplementation partially restored the compromised gut microbiota at both the phylum and genus levels, particularly by increasing Bifidobacterium and Roseburia (p < 0.05). Importantly, questionnaire results suggested that B. breve BB05 administration achieved superior efficacy in relieving diarrhea symptoms and the associated anxiety and depression in college students. An increased fecal concentration of 5-hydroxytryptamine (5-HT) was also observed in the probiotic group, while Acetylcholine (ACH), Epinephrine (EPI), and Noradrenaline/Norepinephrine (NANE) reduced, revealing the potential of B. breve BB05 in alleviating anxiety and depression via modulating the microbiota–gut–brain axis. Furthermore, correlation analysis suggested that the altered microbiota and fecal neurotransmitters were closely associated with the mental symptoms. These results endorse B. breve BB05 intervention as a promising and innovative approach to alleviate both diarrhea and mental health conditions among college students.

Funder

National Natural Science Foundation of China

Double Thousand Plan of Jiangxi Province to Tingtao Chen

Jiangxi Province Key Laboratory of bioengineering drugs

Publisher

MDPI AG

Reference57 articles.

1. Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., and Yin, Y. (2021). Gut microbiota and diarrhea: An updated review. Front. Cell. Infect. Microbiol., 11.

2. Acute diarrhea;Barr;Am. Fam. Physician,2014

3. Traveler’s diarrhea;Grindrod;Can. Fam. Physician Med. Fam. Can.,2019

4. Traveler’s diarrhea;Yates;Am. Fam. Physician,2005

5. ACG Clinical Guideline: Diagnosis, treatment, and prevention of acute diarrheal infections in adults;Riddle;Am. J. Gastroenterol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3